Essex Woodlands Management, Inc. Long-Term Concentrated

Location: The Woodlands, TX

CIK: 0001542339 · Show all filings

Period: Q1 2014 (← Previous) (Next →)

Filing Date: May 15, 2014

Total Value: $393M (100.0% shares, 0.0% debt)

Holdings (11)

— REVANCE THERAPEUTICS INC 36.8%

Value $145M Shares 4,592,047 Est. Cost $31.50 Unrealized —

— HORIZON PHARMA INC 21.7%

Value $85.06M Shares 5,815,940 Est. Cost $2.26 Unrealized —

— ABIOMED INC 20.9%

Value $82.03M Shares 3,150,000 Est. Cost $21.56 Unrealized —

— ENDOLOGIX INC 13.1%

Value $51.55M Shares 1,165,428 Est. Cost $13.28 Unrealized —

— ACURA PHARMACEUTICALS INC 3.6%

Value $14.28M Shares 10,294,886 Est. Cost $1.82 Unrealized —

— ZIOPHARM ONCOLOGY INC 3.0%

Value $11.8M Shares 2,764,908 Est. Cost $1.96 Unrealized —

MNOV MEDICINOVA INC 0.6%

Value $2.399M Shares 1,170,370 Est. Cost $2.95 Unrealized -24.4%

— CURIS INC 0.2%

Value $659K Shares 233,797 Est. Cost $3.19 Unrealized —

— CHINA CORD BLOOD CORP 0.1%

Value $347K Shares 86,763 Est. Cost $2.81 Unrealized —

— ECHO THERAPEUTICS INC 0.0%

Value $37,000 Shares 12,319 Est. Cost $2.52 Unrealized —

— PALATIN TECHNOLOGIES INC 0.0%

Value $29,000 Shares 23,928 Est. Cost $0.59 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	REVANCE THERAPEUTICS INC	4,592,047	$145M	36.8%	$31.50	—	COM	761330109
—	HORIZON PHARMA INC	5,815,940	$85.06M	21.7%	$2.26	—	COM	44047T109
—	ABIOMED INC	3,150,000	$82.03M	20.9%	$21.56	—	COM	003654100
—	ENDOLOGIX INC	1,165,428	$51.55M	13.1%	$13.28	—	COM	29266S106
—	ACURA PHARMACEUTICALS INC	10,294,886	$14.28M	3.6%	$1.82	—	COM NEW	00509L703
—	ZIOPHARM ONCOLOGY INC	2,764,908	$11.8M	3.0%	$1.96	—	COM	98973P101
MNOV	MEDICINOVA INC	1,170,370	$2.399M	0.6%	$2.95	-24.4%	COM NEW	58468P206
—	CURIS INC	233,797	$659K	0.2%	$3.19	—	COM	231269101
—	CHINA CORD BLOOD CORP	86,763	$347K	0.1%	$2.81	—	SHS	G21107100
—	ECHO THERAPEUTICS INC	12,319	$37,000	0.0%	$2.52	—	COM NEW	27876L206
—	PALATIN TECHNOLOGIES INC	23,928	$29,000	0.0%	$0.59	—	COM PAR $ .01	696077403